2018

Last week, the U.S. Food and Drug Administration (“FDA”) released two guidance documents that relate to sharing of certain information about drugs and medical devices, including economic information about unapproved products and unapproved uses, as well as information not included

The OIG recently launched a new compliance resource portal, compiling some of its resources into one user-friendly webpage.

The Compliance Resource Portal provides a list of links to categories of “handy resources for the public that can help ensure that